Dr. Hamid S. Hamdi, M.D.
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Years since graduation
- 41
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 401
Licensed in Texas since 2017, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
TX license R1216 (first issued 2017; active) -
Physical Medicine & Rehabilitation Physician
TX license R1216 (first issued 2017; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Hermann Hospital System Houston, TX
- Memorial Hermann - Texas Medical Center Houston, TX
- Houston Methodist Sugarland Hospital Sugar Land, TX
- Memorial Hermann Katy Hospital Katy, TX
- Memorial Hermann Sugar Land Hospital Sugar Land, TX
Medical groups
- Ut Physicians (213 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 401
- Services billed
- 4,707
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 144 | 114 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 118 | 70 |
| Measurement of brain wave activity (eeg), awake and drowsy | 93 | 86 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 84 | 80 |
| New patient office or other outpatient visit, 45-59 minutes | 83 | 83 |
| Established patient office or other outpatient visit, 20-29 minutes | 70 | 62 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 35 | 34 |
| Needle measurement of electrical activity in arm or leg muscles, limited study | 29 | 21 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 17 | 16 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 15 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Donepezil Hcl Other prescribers in Sugar Land, TX | 429 |
| Memantine Hcl Other prescribers in Sugar Land, TX | 273 |
| Gabapentin Other prescribers in Sugar Land, TX | 220 |
| Levetiracetam Other prescribers in Sugar Land, TX | 162 |
| Pregabalin Other prescribers in Sugar Land, TX | 115 |
| Topiramate Other prescribers in Sugar Land, TX | 111 |
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Sugar Land, TX | 109 |
| Primidone Other prescribers in Sugar Land, TX | 92 |
| Tizanidine Hcl Other prescribers in Sugar Land, TX | 90 |
| Memantine Hcl Er (memantine hcl) Other prescribers in Sugar Land, TX | 84 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 26 payments worth $540 in total to this clinician.
| Abbott Laboratories | $84.94 |
|---|---|
| Argenx US, Inc. | $84.83 |
| Novartis Pharmaceuticals Corporation | $75.83 |
| UCB, Inc. | $68.37 |
| Pfizer Inc. | $59.15 |
| Alexion Pharmaceuticals, Inc. | $43.31 |
| Biogen, Inc. | $26.15 |
| Janssen Biotech, Inc. | $25.90 |
| Food and Beverage | $540 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.